MacDougall 1990.
Methods | Location of trial: Edinburgh, Scotland. Number of centres: 1. Funding: Medical Research Council, Cancer Research Campaign, Scottish Home and Health Department, Lothian Health Board. Trial ID: not stated. |
|
Participants | Inclusion criteria: previously untreated patients with histologically confirmed squamous cell carcinoma of oral cavity, oropharynx, larynx or hypopharynx, less than 80 years old, deemed fit for radiotherapy. Exclusion criteria: primary tumours with high probability of local control with photon treatment. Recruitment period: 1977 to 1984. OC: 66/165 (40%). OP: 35/165 (21%). OC+OP: 101/165 (61%). Number randomised: 165. Number analysed: 165. |
|
Interventions |
Fast neutron radiotherapy versus photon radiotherapy Fast neutron (n = 85): 20 daily fractions over 4 weeks. Total absorbed dose of 15.6 to 16.7 Gy. Photon (n = 80): 20 daily fractions over 4 weeks. Total absorbed dose 54‐56 Gy. |
|
Outcomes | Primary: locoregional control. Secondary: 5 and 10 year survival, disease free survival at 5 years, cause specific survival, late radiation necrosis. Duration of follow‐up: minimum of 5 years, up to 11 years. |
|
Notes | Sample size calculation: based on predicted increase of locoregional control from 40% to 70% it was estimated that 164 patients would be required to show this difference with power of 90% and α = 0.05 on a tow tailed test of significance. Part of multicentre trial but full data from 2 centres not available. Dichotomous data only for outcomes of interest. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Adequate sequence generation? | Low risk | Randomisation stratified on site of primary tumour and presence/absence of malignant lymph nodes. Envelopes containing treatment allocation prepared by trial statistician in Edinburgh, and held by Neutron Clinic secretary. |
Allocation concealment? | Low risk | Sequentially numbered sealed envelopes were drawn. |
Blinding ‐ Outcome Assessors | High risk | Not mentioned. |
Incomplete outcome data addressed? | Low risk | All randomised patients included in analysis. |
Free of selective reporting? | Unclear risk | No planned outcomes listed in methods section. Important outcomes reported. |
Free of other bias? | Unclear risk | Gender imbalance between the groups, unclear if this would introduce a bias. |